Abstract
TOPIC: Critical Care TYPE: Fellow Case Reports INTRODUCTION: MIS-C is described as a clinical syndrome developing secondary to Coronavirus disease 2019 (COVID-19) in children and adolescents. The presentation is similar to Kawasaki syndrome, hemophagocytic lymphohistiocytosis (HLH) and toxic shock syndrome. We present a case of MIS-C in a young adult two weeks after receiving vaccination for COVID-19. CASE PRESENTATION: 21 year old female with a past medical history of asthma who presented to the emergency department (ED) with fevers, chills and photophobia since receiving the JJ223:14–19.e2 REFERENCE #2: CDC COVID-19 Response Team. Coronavirus disease 2019 in children—United States, February 12–April 2, 2020. Morb. Mortal. Wkly. Rep. 2020, 69, 422–426. DISCLOSURES: No relevant relationships by Bilal Bangash, source=Web Response No relevant relationships by Issa Makki, source=Web Response No relevant relationships by Joseph Pitcher, source=Web Response
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
